Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clapham

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Disasters|October 21, 2010
The structure of regional conflict in northern ethiopiaC Clapham
Methods in Molecular Biology (Clifton, N.J.)|October 6, 2019
Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now?John C Clapham
Idrugs : the Investigational Drugs Journal|March 11, 2004
Fat oxidation in obesity: druggable or risky enterprise?John C Clapham
Journal of Cardiovascular Pharmacology|January 1, 1988
A method for in vivo assessment of calcium slow channel blocking drugsJ C Clapham
Journal of Cardiovascular Pharmacology|July 1, 1984
Interaction between nifedipine and postsynaptic alpha 1- and alpha 2-adrenoceptors following oral pretreatment of spontaneously hypertensive ratsJ C Clapham
Annals of Clinical Biochemistry|January 1, 1991
Assessment of oxygenation in the critically illM C Clapham
Neuropharmacology|November 9, 2011
Central control of thermogenesisJohn C Clapham
Current Drug Targets|April 3, 2004
Treating obesity: pharmacology of energy expenditureJohn C Clapham
Expert Opinion on Drug Discovery|March 15, 2013
Cell based in vitro and ex vivo models in metabolic disease drug discovery: nice to have or critical path?Stefan Hallén, John C Clapham
Journal of Autonomic Pharmacology|September 1, 1987
Anti-spasmogenic and spasmolytic effects of BRL 34915: a comparison with nifedipine and nicorandilJ C Clapham, C Wilson
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Disasters|October 21, 2010
The structure of regional conflict in northern ethiopiaC Clapham
Methods in Molecular Biology (Clifton, N.J.)|October 6, 2019
Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now?John C Clapham
Idrugs : the Investigational Drugs Journal|March 11, 2004
Fat oxidation in obesity: druggable or risky enterprise?John C Clapham
Journal of Cardiovascular Pharmacology|January 1, 1988
A method for in vivo assessment of calcium slow channel blocking drugsJ C Clapham
Journal of Cardiovascular Pharmacology|July 1, 1984
Interaction between nifedipine and postsynaptic alpha 1- and alpha 2-adrenoceptors following oral pretreatment of spontaneously hypertensive ratsJ C Clapham
Annals of Clinical Biochemistry|January 1, 1991
Assessment of oxygenation in the critically illM C Clapham
Neuropharmacology|November 9, 2011
Central control of thermogenesisJohn C Clapham
Current Drug Targets|April 3, 2004
Treating obesity: pharmacology of energy expenditureJohn C Clapham
Expert Opinion on Drug Discovery|March 15, 2013
Cell based in vitro and ex vivo models in metabolic disease drug discovery: nice to have or critical path?Stefan Hallén, John C Clapham
Journal of Autonomic Pharmacology|September 1, 1987
Anti-spasmogenic and spasmolytic effects of BRL 34915: a comparison with nifedipine and nicorandilJ C Clapham, C Wilson
Pageof 9